191 related articles for article (PubMed ID: 27234566)
1. Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer.
Kini Bailur J; Gueckel B; Pawelec G
J Transl Med; 2016 May; 14(1):151. PubMed ID: 27234566
[TBL] [Abstract][Full Text] [Related]
2. Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
Bailur JK; Gueckel B; Derhovanessian E; Pawelec G
Breast Cancer Res; 2015 Mar; 17(1):34. PubMed ID: 25849846
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.
Chevolet I; Speeckaert R; Schreuer M; Neyns B; Krysko O; Bachert C; Van Gele M; van Geel N; Brochez L
J Transl Med; 2015 Jan; 13():9. PubMed ID: 25592374
[TBL] [Abstract][Full Text] [Related]
4. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.
Song QK; Ren J; Zhou XN; Wang XL; Song GH; Di LJ; Yu J; Hobeika A; Morse MA; Yuan YH; Yang HB; Lyerly HK
Oncotarget; 2015 Dec; 6(38):41350-9. PubMed ID: 26462021
[TBL] [Abstract][Full Text] [Related]
7. CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.
Speigl L; Burow H; Bailur JK; Janssen N; Walter CB; Pawelec G; Shipp C
Breast Cancer Res Treat; 2018 Apr; 168(2):401-411. PubMed ID: 29230664
[TBL] [Abstract][Full Text] [Related]
8. Long-term Follow-up After Interstitial Laser Thermotherapy of Breast Cancer.
Haraldsdóttir KH; Ingvar C; Stenram U; Tranberg KG
Anticancer Res; 2015 Nov; 35(11):6147-52. PubMed ID: 26504041
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma.
Butsch R; Lukas Waelti S; Schaerer S; Braun J; Korol D; Probst-Hensch N; Moch H; Kurrer M
Leuk Lymphoma; 2011 Jul; 52(7):1230-8. PubMed ID: 21599580
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.
Zhou ZJ; Xin HY; Li J; Hu ZQ; Luo CB; Zhou SL
Cancer Immunol Immunother; 2019 Aug; 68(8):1223-1233. PubMed ID: 31201473
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD8
Song Q; Ren J; Zhou X; Wang X; Song G; Hobeika A; Yuan Y; Lyerly HK
Cytotherapy; 2018 Jan; 20(1):126-133. PubMed ID: 28988693
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.
Solis-Castillo LA; Garcia-Romo GS; Diaz-Rodriguez A; Reyes-Hernandez D; Tellez-Rivera E; Rosales-Garcia VH; Mendez-Cruz AR; Jimenez-Flores JR; Villafana-Vazquez VH; Pedroza-Gonzalez A
Breast Cancer; 2020 Sep; 27(5):837-849. PubMed ID: 32180141
[TBL] [Abstract][Full Text] [Related]
13. Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8
Chen H; Chen Y; Liu H; Que Y; Zhang X; Zheng F
Front Immunol; 2018; 9():1179. PubMed ID: 29896199
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
[TBL] [Abstract][Full Text] [Related]
15. A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E; Martorelli D; Turchet E; Miolo G; Scalone S; Comaro E; Talamini R; Mastorci K; Lombardi D; Perin T; Carbone A; Veronesi A; Crivellari D; Dolcetti R
Breast Cancer Res; 2011; 13(6):R117. PubMed ID: 22112244
[TBL] [Abstract][Full Text] [Related]
16. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.
Ladoire S; Mignot G; Dabakuyo S; Arnould L; Apetoh L; Rébé C; Coudert B; Martin F; Bizollon MH; Vanoli A; Coutant C; Fumoleau P; Bonnetain F; Ghiringhelli F
J Pathol; 2011 Jul; 224(3):389-400. PubMed ID: 21437909
[TBL] [Abstract][Full Text] [Related]
17. The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients.
Charles J; Chaperot L; Revol B; Baudin M; Mouret S; Hamon A; Leccia MT; Plumas J; Aspord C
Pigment Cell Melanoma Res; 2018 Jan; 31(1):82-94. PubMed ID: 28741900
[TBL] [Abstract][Full Text] [Related]
18. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
[TBL] [Abstract][Full Text] [Related]
19. Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study.
Paek SH; Kim HG; Lee JW; Woo J; Kwon H; Kim JB; Lim W; Kim JR; Moon BI; Paik NS
J Breast Cancer; 2019 Mar; 22(1):29-37. PubMed ID: 30941231
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
Zhu S; Lin J; Qiao G; Xu Y; Zou H
Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
